NIAID is offering this grant to support research aimed at advancing the development of a universal influenza vaccine to provide lasting protection against multiple influenza strains. Research areas include improving understanding of influenza infection, defining immunity, and designing universal vaccines. This grant opportunity utilizes the R01 grant mechanism and is suitable for applicants with preliminary data or planning longer-term studies. High-risk projects without preliminary data may be better suited for the companion FOA using the R21 mechanism. Closing date for applications is September 7, 2021.
Opportunity ID: 307232
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PA-18-859 |
| Funding Opportunity Title: | Advancing Research Needed to Develop a Universal Influenza Vaccine (R01 Clinical Trial Not Allowed) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.855 — Allergy and Infectious Diseases Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Jul 18, 2018 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | Sep 07, 2021 |
| Current Closing Date for Applications: | Sep 07, 2021 |
| Archive Date: | Oct 13, 2021 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | County governments Special district governments Others (see text field entitled “Additional Information on Eligibility” for clarification) Native American tribal organizations (other than Federally recognized tribal governments) City or township governments State governments For profit organizations other than small businesses Public housing authorities/Indian housing authorities Public and State controlled institutions of higher education Private institutions of higher education Native American tribal governments (Federally recognized) Independent school districts Small businesses Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | The purpose of this Funding Opportunity Announcement is to support research activities that will advance NIAIDs mission to develop a universal influenza vaccine providing durable protection against multiple influenza strains, including efforts to: 1) improve understanding of transmission, natural history and pathogenesis of influenza virus infection; 2) characterize influenza immunity and correlates of immune protection; and 3) support rational design of universal influenza vaccines. This FOA uses the R01 grant mechanism, while the companion FOA, PA-XX-xxx , uses the R21 mechanism. Applicants with preliminary data and/or planning longer-term studies may wish to apply using the R01 mechanism. High risk/high payoff projects that lack preliminary data or utilize existing data may be most appropriate for the R21 mechanism. . |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PA-18-859.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-E | Use for due dates on or before May 24, 2020 | PKG00243841 | Sep 05, 2018 | May 24, 2020 | View | |
| FORMS-F | Use for due dates on or after May 25, 2020 | PKG00259208 | Sep 05, 2018 | Sep 07, 2021 | View |
Package 1
Mandatory forms
307232 RR_SF424_2_0-2.0.pdf
307232 PHS398_CoverPageSupplement_4_0-4.0.pdf
307232 RR_OtherProjectInfo_1_4-1.4.pdf
307232 PerformanceSite_2_0-2.0.pdf
307232 RR_KeyPersonExpanded_2_0-2.0.pdf
307232 PHS398_ResearchPlan_4_0-4.0.pdf
Optional forms
307232 RR_Budget_1_4-1.4.pdf
307232 RR_SubawardBudget30_1_4-1.4.pdf
307232 PHS398_ModularBudget_1_2-1.2.pdf
307232 PHS_AssignmentRequestForm_2_0-2.0.pdf
Package 2
Mandatory forms
307232 RR_SF424_2_0-2.0.pdf
307232 PHS398_CoverPageSupplement_5_0-5.0.pdf
307232 RR_OtherProjectInfo_1_4-1.4.pdf
307232 PerformanceSite_2_0-2.0.pdf
307232 RR_KeyPersonExpanded_2_0-2.0.pdf
307232 PHS398_ResearchPlan_4_0-4.0.pdf
307232 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf
Optional forms
307232 RR_Budget_1_4-1.4.pdf
307232 RR_SubawardBudget30_1_4-1.4.pdf
307232 PHS398_ModularBudget_1_2-1.2.pdf
307232 PHS_AssignmentRequestForm_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
